Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr

Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr

By: IPP Bureau

Last updated : May 12, 2023 11:15 am



The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023


Bliss GVS Pharma Limited has posted net profit Rs. 3.34 crores for the period ended March 31, 2023 as against net profit of Rs. 27.94 crores for the period ended December 31, 2022. The company posted net profit of Rs.19.63 crores for the period ended March 31, 2022.

The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023 as compared to Rs. 211.36 crores during the period ended December 31, 2022. It reported total income of Rs.179.25 crores during the period ended March 31, 2022.

For the Financial Year ended March 31, 2023, Bliss GVS Pharma has reported total income of Rs.769.37 crores as compared to Rs.778.94 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.70.85 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.15.04 crores for the Financial Year ended March 31, 2022.

Bliss GVS Pharma Limited

First Published : May 12, 2023 12:00 am